Covered recipient · General Payments record
INGRIDA PAKALNISKYTE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$805.99
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.72 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $76.82 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $39.97 | 2 |
| Incyte Corporation | $39.22 | 2 |
| Daiichi Sankyo Inc. | $35.42 | 2 |
| Janssen Biotech, Inc. | $33.75 | 1 |
| Kite Pharma, Inc. | $20.86 | 1 |
| Ipsen Biopharmaceuticals, Inc | $19.36 | 1 |
| Astellas Pharma US Inc | $19.17 | 1 |
| PFIZER INC. | $17.75 | 1 |
| EISAI INC. | $17.03 | 1 |
| GENZYME CORPORATION | $15.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.08 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107779153 | CMS |
| ABBVIE INC. | $18.96 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107779155 | CMS |
| ABBVIE INC. | $28.91 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107779157 | CMS |
| ABBVIE INC. | $13.87 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107779159 | CMS |
| Astellas Pharma US Inc | $19.17 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139554575 | CMS |
| Daiichi Sankyo Inc. | $14.32 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089465680 | CMS |
| Daiichi Sankyo Inc. | $21.10 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089465678 | CMS |
| Eisai Inc. | $17.03 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110803544 | CMS |
| GENZYME CORPORATION | $15.37 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139783981 | CMS |
| Incyte Corporation | $18.94 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141301621 | CMS |
| Incyte Corporation | $20.28 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141262601 | CMS |
| Ipsen Biopharmaceuticals, Inc | $19.36 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091991681 | CMS |
| Janssen Biotech, Inc. | $33.75 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078337936 | CMS |
| Kite Pharma, Inc. | $20.86 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128612997 | CMS |
| Novartis Pharmaceuticals Corporation | $16.23 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087243309 | CMS |
| Novartis Pharmaceuticals Corporation | $23.74 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087243315 | CMS |
| PFIZER INC. | $17.75 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131346602 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.